PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.
about
Copy number variability in Parkinson's disease: assembling the puzzle through a systems biology approachNeuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases.Pituitary adenylate cyclase activating polypeptide modulates catecholamine storage and exocytosis in PC12 cells.Comparative protein composition of the brains of PACAP-deficient mice using mass spectrometry-based proteomic analysis.Chronic salsolinol administration prevents the behavioral and neurochemical effects of L-DOPA in rats.Age-related decline of autocrine pituitary adenylate cyclase-activating polypeptide impairs angiogenic capacity of rat cerebromicrovascular endothelial cells.Dose-dependent effect of Curcuma longa for the treatment of Parkinson's diseaseTherapeutic potential of PACAP for neurodegenerative diseases.PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells: Implications for Drinking-Smoking Co-morbidity.PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.PACAP enhances barrier properties of cerebral microvessels.Pinocembrin protects SH-SY5Y cells against MPP+-induced neurotoxicity through the mitochondrial apoptotic pathway.Protective effects of curcumin against rotenone and salsolinol-induced toxicity: implications for Parkinson's disease.Characterization of the thermoregulatory response to pituitary adenylate cyclase-activating polypeptide in rodents.Alteration of the PAC1 Receptor Expression in the Basal Ganglia of MPTP-Induced Parkinsonian Macaque Monkeys.Salsolinol: an Unintelligible and Double-Faced Molecule-Lessons Learned from In Vivo and In Vitro Experiments.
P2860
Q33364337-F9022BBD-1CBC-4A03-A395-D828E871C146Q34179881-94F0BC23-D1A2-40D7-9F0E-F990C09D8FB3Q35113313-F256479A-B2EE-4D78-BB8E-B191CBC81C1EQ35124417-14A3AC30-BC3C-4796-95E8-32E78BC88C1FQ35252890-81DD6F32-B5E8-4ECA-AAE4-D02A8C7EFC8AQ35661804-F7E459BF-EB90-40DC-97BE-374793FA56A2Q36387938-E31820E4-BFB7-4236-9E5D-2813B8A807EFQ38552803-F34FFECB-20FC-4C4A-AEFB-BD0C76493E45Q38710584-5B1D91DA-2FAD-41A1-A517-92D1F516B146Q39003365-8E7DD5B8-B4B7-4F5C-8521-666F0C7D8E44Q39016755-FC2C0EB0-C49A-4CBE-B828-02966C724EA0Q39036997-A5ADB1C9-9EA2-43C5-9621-AF85B74F6FDEQ39079698-E1C88E62-BF52-4A78-A38B-F11218AC4265Q40201264-23BE47F0-F472-4340-9849-B317307559ABQ47303830-6504B1F5-76B6-4B19-B937-1AEF064AE07DQ48004001-200ECEFA-5E8D-4357-8A43-6DBF012B2D07
P2860
PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
PACAP protects against salsoli ...... ation for Parkinson's disease.
@en
PACAP protects against salsoli ...... ation for Parkinson's disease.
@nl
type
label
PACAP protects against salsoli ...... ation for Parkinson's disease.
@en
PACAP protects against salsoli ...... ation for Parkinson's disease.
@nl
prefLabel
PACAP protects against salsoli ...... ation for Parkinson's disease.
@en
PACAP protects against salsoli ...... ation for Parkinson's disease.
@nl
P2093
P2860
P1476
PACAP protects against salsoli ...... ation for Parkinson's disease.
@en
P2093
Andrea Tamas
Dora Reglödi
Dwayne Brown
Yousef Tizabi
P2860
P2888
P304
P356
10.1007/S12031-013-0015-7
P577
2013-04-28T00:00:00Z